Saturday - November 23, 2024
MD Anderson Research Highlights: ASCO 2024 Special Edition
May 24, 2024
HOUSTON, Texas, May 24 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:

* * *

Featuring clinical trial results for leptomeningeal metastases, lymphoma and melanoma, biomarkers for anal cancer recurrence, and immunotherapy to prevent oral cancer

* * *

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prev . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products